Metallothionein and Apoptosis during Differentiation of Myoblasts to Myotubes: Protection against Free Radical Toxicity

Margarita D. Apostolova,Iordanka A. Ivanova,M.George Cherian
DOI: https://doi.org/10.1006/taap.1999.8755
IF: 4.46
1999-09-01
Toxicology and Applied Pharmacology
Abstract:The changes in subcellular localization of metallothionein (MT) during differentiation were studied in two muscle cell lines, L6 and H9C2, myoblasts in order to understand the nuclear presence of MT and its antiapoptotic property. In myoblasts, MT and zinc were localized mainly in the cytoplasm but were translocated into the nucleus of newly formed myotubes during early stage of differentiation, which was initiated by lowering FBS from 10% to 1%. In fully differentiated myotubes, metallothionein content was decreased with a cytoplasmic localization. These changes in subcellular localization of MT and Zn were accompanied by increased apoptosis in myotubes. The changes in the apoptosis at different stages of differentiation were measured by both DNA ladder formation and TUNEL technique. The results also show that the apoptosis may be initiated by free radical generation and may be accompanied by p53 expression. The H9C2 cells contained high levels of MT, differentiated slowly, and had low incidence of apoptotic bodies compared to L6 cell line.
pharmacology & pharmacy,toxicology
What problem does this paper attempt to address?